US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. September 21, 2021

    Ohio Counties Want Unvaxxed Jurors Out Of Opioid MDL Trial

    Two Ohio counties involved in an upcoming bellwether trial against pharmacies in sprawling multidistrict opioid litigation asked an Ohio federal judge on Tuesday to exclude nearly 40 potential jurors who are not vaccinated against COVID-19, saying that allowing unvaccinated jurors to serve on the jury would be likely to disrupt the trial.

  2. September 20, 2021

    Judge Limits Stanford Doctor's Testimony In Opioid MDL

    An Ohio federal judge narrowed what a Stanford University doctor will be allowed to testify about when it comes to aspects of opioid pharmacy operations during an upcoming bellwether trial, but she will allow the expert to speak on alleged "red flags" the industry ignored.

  3. September 17, 2021

    Endo's Attys In 'Career-Wrecking' Peril As Opioid Woes Grow

    A flash flood of misconduct inquiries in opioid litigation across the country is rapidly engulfing Endo Pharmaceuticals and threatening to inflict considerable damage on the professional reputations of its Arnold & Porter attorneys, according to legal filings, court proceedings and interviews.

  4. September 14, 2021

    'Red Flag' Expert's Opinion Limited In Opioid MDL

    An Ohio federal judge will limit the scope of an expert's testimony about how pharmacies failed to heed "red flags" meant to curb the diversion of opioids, saying he can opine that the alleged failure likely led to the drugs getting out on the streets, but he cannot establish a direct causal link.

  5. September 08, 2021

    Opioid MDL's Tribal Bellwether Paused, Global Deal Possible

    An Oklahoma federal judge on Wednesday paused key proceedings in the bellwether case for Native American tribes in multidistrict opioid litigation after the Cherokee Nation and the country's largest drug distributors indicated that a major settlement might be imminent.

  6. August 26, 2021

    Rite Aid Strikes Deal To Avert Opioid MDL's 1st Pharmacy Trial

    A years-in-the-making opioid trial against major pharmacy chains won't include Rite Aid Corp., which revealed a deal Thursday to avoid going before an Ohio federal jury on allegations it unlawfully dispensed and distributed massive amounts of prescription narcotics.

  7. August 20, 2021

    NJ Joins $26B Opioid Settlement With J&J, Pharma Cos.

    New Jersey intends to join a $26 billion settlement with Johnson & Johnson and three pharmaceutical distribution companies in sprawling multidistrict litigation over the companies' roles in the opioid crisis, acting Attorney General Andrew J. Bruck said Friday.

  8. August 18, 2021

    Grocery Chain Wants Out Of Ohio Counties' Opioid Bellwether

    A regional supermarket chain on Tuesday told the Ohio federal judge overseeing the multidistrict litigation over the opioid crisis that it should be let out of public nuisance claims brought by two counties in an upcoming bellwether trial since it has a decadelong history of compliance with anti-diversion laws.

  9. August 17, 2021

    'No End In Sight' As Endo, Arnold & Porter Reveal Opioid Files

    The conduct of Endo Pharmaceuticals and its Arnold & Porter attorneys has thoroughly tainted discovery in multidistrict opioid litigation, an Illinois federal judge heard Tuesday, shortly after new disclosures showed that the law firm was recently threatened with a possible referral to the state bar authorities.

  10. August 13, 2021

    Ohio Counties Don't Want 'Legal Opioid' Talk In Bellwether

    Two Ohio counties set for an October bellwether trial over the opioid crisis want their pharmacy-chain adversaries blocked from calling prescription opioids "legal opioids," saying it will only confuse matters since legality is dependent on context.